JP2016511281A5 - - Google Patents

Download PDF

Info

Publication number
JP2016511281A5
JP2016511281A5 JP2015562366A JP2015562366A JP2016511281A5 JP 2016511281 A5 JP2016511281 A5 JP 2016511281A5 JP 2015562366 A JP2015562366 A JP 2015562366A JP 2015562366 A JP2015562366 A JP 2015562366A JP 2016511281 A5 JP2016511281 A5 JP 2016511281A5
Authority
JP
Japan
Prior art keywords
erythro
benzoyl
under conditions
conditions effective
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015562366A
Other languages
English (en)
Japanese (ja)
Other versions
JP6438417B2 (ja
JP2016511281A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/000494 external-priority patent/WO2014140787A2/en
Publication of JP2016511281A publication Critical patent/JP2016511281A/ja
Publication of JP2016511281A5 publication Critical patent/JP2016511281A5/ja
Application granted granted Critical
Publication of JP6438417B2 publication Critical patent/JP6438417B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015562366A 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法 Active JP6438417B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361801641P 2013-03-15 2013-03-15
US61/801,641 2013-03-15
EP13306056.6 2013-07-23
EP13306056 2013-07-23
PCT/IB2014/000494 WO2014140787A2 (en) 2013-03-15 2014-03-14 Methods for the synthesis of sphingomyelins and dihydrosphingomyelins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018117808A Division JP2018168171A (ja) 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Publications (3)

Publication Number Publication Date
JP2016511281A JP2016511281A (ja) 2016-04-14
JP2016511281A5 true JP2016511281A5 (enExample) 2017-02-02
JP6438417B2 JP6438417B2 (ja) 2018-12-12

Family

ID=51538203

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562366A Active JP6438417B2 (ja) 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法
JP2018117808A Pending JP2018168171A (ja) 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018117808A Pending JP2018168171A (ja) 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Country Status (16)

Country Link
US (3) US20140316154A1 (enExample)
EP (3) EP3842443B1 (enExample)
JP (2) JP6438417B2 (enExample)
KR (1) KR20150132188A (enExample)
CN (1) CN105051051B (enExample)
AU (2) AU2014229638B2 (enExample)
BR (1) BR112015023558A2 (enExample)
CA (1) CA2900902C (enExample)
DK (1) DK3363805T3 (enExample)
ES (1) ES3017659T3 (enExample)
HK (1) HK1214266A1 (enExample)
MX (1) MX387128B (enExample)
PH (1) PH12015501835B1 (enExample)
SG (2) SG11201506456VA (enExample)
WO (1) WO2014140787A2 (enExample)
ZA (1) ZA201505860B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2396017T3 (en) 2009-02-16 2015-09-14 Cerenis Therapeutics Holding Sa Apolipoprotein A-I-mimetika
SG189019A1 (en) 2010-10-18 2013-05-31 Cerenis Therapeutics Holding Sa Compounds, compositions and methods useful for cholesterol mobilisation
CN105051051B (zh) 2013-03-15 2021-07-16 萨瑞斯治疗控股公司 用于合成神经鞘磷脂和二氢神经鞘磷脂的方法
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
TW201919686A (zh) 2017-08-10 2019-06-01 法商塞勒尼斯醫療控股公司 脫輔基子(apomers)
WO2019030574A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding Cargomers
US20210017202A1 (en) * 2018-03-27 2021-01-21 Nof Corporation Sphingomyelin-derived lipid and method for producing same
JP7303618B2 (ja) * 2018-10-05 2023-07-05 日本精化株式会社 スフィンゴリン脂質前駆体及びその製造方法、並びに、スフィンゴリン脂質の製造方法
EP4135747A1 (en) 2020-04-16 2023-02-22 Abionyx Pharma SA Methods for treating acute conditions using lipid binding protein- based complexes
CN115666720A (zh) 2020-04-16 2023-01-31 阿比奥尼克斯制药公司 用于治疗肾病的cer-001疗法
WO2021209808A1 (en) 2020-04-16 2021-10-21 Abionyx Pharma Sa Cer-001 therapy for treating kidney disease
JP2023543498A (ja) 2020-10-01 2023-10-16 アビオニクス ファーマ エスエー 脂質結合タンパク質ベースの複合体を使用した、眼疾患を治療するための方法
JP2024514154A (ja) 2021-04-15 2024-03-28 アビオニクス ファーマ エスエー 臓器保存溶液における脂質結合タンパク質ベースの複合体の使用
EP4504233A1 (en) 2022-04-06 2025-02-12 Abionyx Pharma SA Methods for treating leukocytosis, endothelial dysfunction and carditis using lipid binding protein-based complexes
EP4504150A1 (en) 2022-04-06 2025-02-12 Abionyx Pharma SA Methods for treating eye diseases using lipid binding protein-based complexes
EP4536269A2 (en) 2022-06-10 2025-04-16 Abionyx Pharma SA Methods for treating acute conditions using lipid binding protein-based complexes
CN120344255A (zh) 2022-06-10 2025-07-18 阿比奥尼克斯制药公司 使用基于脂质结合蛋白的复合物治疗过度炎性病症的方法
IL317896A (en) 2022-06-28 2025-02-01 Abionyx Pharma Sa Compounds and processes for the synthesis of sphingomyelins
AU2024207875A1 (en) 2023-01-13 2025-07-24 Abionyx Pharma Sa Lipid binding protein molecule therapy
WO2025093929A1 (en) 2023-10-31 2025-05-08 Abionyx Pharma Sa Lipid binding protein molecule therapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146810A3 (de) 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US5220043A (en) * 1991-03-21 1993-06-15 Ohio University Synthesis of D-erythro-sphingomyelins
NZ276305A (en) 1993-11-16 1997-10-24 Depotech Corp Controlled release vesicle compositions
US5766627A (en) 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
AU765809B2 (en) * 1998-02-12 2003-10-02 Emory University Sphingolipid derivatives and their methods of use
JP2004002215A (ja) * 2002-05-23 2004-01-08 National Institute Of Advanced Industrial & Technology スフィンゴ脂質誘導体の製造方法
WO2005068480A1 (en) 2004-01-15 2005-07-28 Biolab Ltd. Sphingomyelin, intermediates thereof and methods for preparation of same
CA2566559C (en) 2004-05-17 2014-05-06 Inex Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
DE602005011802D1 (de) 2004-06-29 2009-01-29 Jado Technologies Gmbh Afts
JP4825947B2 (ja) 2004-08-04 2011-11-30 学校法人関西学院 不飽和アミノジオール類の製造方法
JP2006045113A (ja) 2004-08-04 2006-02-16 Kemikurea:Kk リン酸エステル類
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US7470664B2 (en) * 2005-07-20 2008-12-30 Merck & Co., Inc. HCV NS3 protease inhibitors
JP2007204384A (ja) 2006-01-31 2007-08-16 Kemikurea:Kk 光学活性リン酸誘導体およびこれを用いた光学活性スフィンゴシン1−リン酸誘導体の製造方法
JP5429734B2 (ja) * 2007-02-09 2014-02-26 国立大学法人岐阜大学 スフィンゴ糖脂質の合成法
JP5178707B2 (ja) 2007-03-09 2013-04-10 株式会社糖鎖工学研究所 スフィンゴシン化合物、その製造方法及びスフィンゴミエリナーゼ阻害剤
AU2009302042A1 (en) 2008-10-07 2010-04-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Liposomal systems comprising sphingomyelin
HUE042314T2 (hu) 2011-02-07 2019-06-28 Cerenis Therapeutics Holding Sa Lipoprotein komplexek és azok gyártása és alkalmazásai
FR3000959B1 (fr) * 2013-01-14 2015-08-21 Holis Technologies Nouveaux intermediaires de synthese permettant d'acceder avec de bons rendements a des derives de sphingosines, ceramides et sphingomyelines
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
CN105051051B (zh) * 2013-03-15 2021-07-16 萨瑞斯治疗控股公司 用于合成神经鞘磷脂和二氢神经鞘磷脂的方法

Similar Documents

Publication Publication Date Title
JP2016511281A5 (enExample)
US9708354B2 (en) Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
TWI709567B (zh) 抗病毒核苷酸類似物的製備方法
US20170204122A1 (en) Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
JP2012515142A5 (enExample)
RU2012141048A (ru) Композиция прокатализатора с замещенным амидоэфиром в качестве внутреннего донора электронов
JP2014530809A5 (enExample)
EP3077404A2 (en) Purification of tenofovir alafenamide and its intermediates
RU2015105294A (ru) Способ получения тенелиглиптина
JP2015527345A5 (enExample)
EP3805199A4 (en) PROCESS FOR PREPARATION OF PREGABALIN INTERMEDIATE (R)-3(CARBAMOYLMETHYL)-5-METHYLHEXAID
JP2017515949A5 (enExample)
CA2812178A1 (en) Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof
CN105237560A (zh) 一种lzc696中间体及其合成方法
EP2970102B1 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
JP2018536645A5 (enExample)
JP2012017285A5 (enExample)
JP2017513885A5 (enExample)
JP2019526552A5 (enExample)
RU2005127872A (ru) Оптически активные соединения бисоксазолина, способ их получения и применение
JP6139694B2 (ja) ホスホン酸モノマーの調製のためのプロセス
Nieves et al. Approaches to polyunsaturated sphingolipids: new conformationally restrained analogs with minimal structural modifications
AR081836A1 (es) Proceso para la produccion de aliskiren, procedimiento para la preparacion de intermediarios para su sintesis y compuestos necesarios para obtener estos ultimos
JP6011999B2 (ja) アミノ酸イオン液体を用いたn−アシルアミノ酸又はn−アシルペプチドの製造方法
CN1871246A (zh) {2-[(8,9)-二氧代-2,6-二氮杂-双环[5.2.0]-壬-1(7)-烯-2-基]乙基}膦酸及其酯的制备方法